JJBC
James J. Burns & Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $339K | Buy |
4,084
+1,027
| +34% | +$85.2K | 0.06% | 112 |
|
2025
Q1 | $248K | Buy |
3,057
+4
| +0.1% | +$324 | 0.04% | 130 |
|
2024
Q4 | $275K | Buy |
3,053
+29
| +1% | +$2.61K | 0.05% | 127 |
|
2024
Q3 | $299K | Buy |
3,024
+49
| +2% | +$4.85K | 0.05% | 110 |
|
2024
Q2 | $275K | Buy |
+2,975
| New | +$275K | 0.05% | 107 |
|
2024
Q1 | – | Sell |
-2,993
| Closed | -$267K | – | 124 |
|
2023
Q4 | $267K | Sell |
2,993
-69
| -2% | -$6.16K | 0.06% | 101 |
|
2023
Q3 | $224K | Buy |
3,062
+146
| +5% | +$10.7K | 0.06% | 96 |
|
2023
Q2 | $242K | Sell |
2,916
-178
| -6% | -$14.8K | 0.06% | 100 |
|
2023
Q1 | $236K | Buy |
+3,094
| New | +$236K | 0.06% | 105 |
|